title: Restoring tacrolimus-induced impaired barrier function.
authors.affiliation: Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
authors.forename: Cheryl
authors.initials: C
authors.lastname: Aber
authors.forename: Robert S
authors.initials: RS
authors.lastname: Kirsner
mesh_terms: D000634:Aminoquinolines / Q000494:pharmacology; D000818:Animals; D023181:Antimicrobial Cationic Peptides; D054804:Cathelicidins / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects* / Q000502:physiology; D002463:Cell Membrane Permeability / Q000187:drug effects* / Q000502:physiology; D003876:Dermatitis, Atopic / Q000188:drug therapy; D000078404:Epidermal Cells; D004817:Epidermis / Q000187:drug effects* / Q000503:physiopathology*; D006801:Humans; D000077271:Imiquimod; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D053582:Interleukin-1alpha / Q000494:pharmacology*; D050356:Lipid Metabolism / Q000187:drug effects; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D017472:Receptors, Interleukin-1 / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use; D023083:beta-Defensins / Q000378:metabolism
chemical_list: D000634:Aminoquinolines; D023181:Antimicrobial Cationic Peptides; D054804:Cathelicidins; D007166:Immunosuppressive Agents; D053582:Interleukin-1alpha; D017472:Receptors, Interleukin-1; D023083:beta-Defensins; C540070:beta-defensin 3, mouse; D000077271:Imiquimod; D016559:Tacrolimus